July 18, 2022
NexImmune Announces IND Clearance by the US FDA for NEXI-003 for the Treatment of HPV-Related Cancers
First IND for NexImmune’s AIM nanoparticle platform in solid tumors IND clearance enables commencement of a clinical trial to evaluate…
July 18, 2022
Novavax receives FDA authorization for its Covid vaccine – Washington Business Journal
The announcement comes days after the Biden administration reached a deal to buy 3.2 million doses. Image: Novavax has received…
July 13, 2022
MaxCyte Signs Strategic Platform License with LG Chem to Advance its Allogeneic CAR-T Programs
LG Chem to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to accelerate the development of its T-cell therapy candidates…
July 11, 2022
NRL Announces the Washington Metropolitan Quantum Network Research Consortium (DC-QNet)
WASHINGTON – To advance quantum network capabilities and leadership, the U.S. Naval Research Laboratory (NRL) announced work with five other U.S. Government…
